Can thyroid antibodies go away on their own?

Rarely. The AACE/ATA hypothyroidism guideline notes that once thyroid antibodies appear, they generally persist and seldom disappear spontaneously. Titers can fall, for example by about 60% during pregnancy, but they usually return afterward. A falling titer does not mean the risk is gone.

Do I need to repeat the antibody test every year?

No. Once you know you are antibody positive, the result does not change management. The useful yearly test is TSH, which shows whether the thyroid is still keeping up. Repeat antibody testing adds cost without changing the plan.

Does a very high antibody number mean my thyroid will fail sooner?

Higher titers carry higher risk, and the effect is level dependent. But TSH is a much stronger predictor than the antibody number. A person with a huge titer and a TSH of 1.0 is at lower near-term risk than a person with a modest titer and a TSH of 6.0.

Should my family members get tested for thyroid antibodies?

Relatives of people with Hashimoto's or Graves' disease have a higher risk, and the Amsterdam cohort found two affected relatives carried the most risk. Guidelines do not call for routine antibody screening of relatives. A TSH test is reasonable if a relative has symptoms, is pregnant, or is planning pregnancy.

If I am antibody positive and want to get pregnant, what should I do first?

Get a TSH test before conception and tell your obstetrician about the antibody result. The ATA 2017 guideline recommends TSH checks every 4 weeks through midpregnancy for antibody-positive women, and treatment if TSH rises above the pregnancy-specific range. If you have had a prior pregnancy loss, ask whether low-dose levothyroxine is appropriate for you.

Do Thyroid Antibodies Mean You Will Get Hypothyroidism?

The short answer: No. Positive thyroid antibodies raise your risk of hypothyroidism, but they do not make it certain. In the 20-year Whickham follow-up, women with antibodies and a normal TSH developed hypothyroidism at roughly 2% to 3% per year. The risk jumps when TSH is also above the reference range. Outside pregnancy, guidelines do not recommend levothyroxine while TSH is normal. The usual plan is a TSH check about once a year.

What are TPO and thyroglobulin antibodies?

Thyroid peroxidase (TPO) is the enzyme the thyroid uses to build hormone. Thyroglobulin (Tg) is the protein that stores it. Antibodies against either one mean the immune system is targeting thyroid tissue. That process is Hashimoto's thyroiditis. NIDDK notes that TPO antibodies are present in most people with Hashimoto's disease.

MedlinePlus describes three antibody tests. High TPO antibodies (TPOAb) and thyroglobulin antibodies (TgAb) point to Hashimoto's. TSH receptor antibodies (TRAb) point to Graves' disease instead.

Antibodies measure the immune attack, not thyroid function. TSH and free T4 measure function; see our guide to thyroid blood tests. A person can have high antibodies and a normal TSH for decades.

How common are positive antibodies with a normal TSH?

Very common. The NHANES III survey tested 17,353 Americans. TPO antibodies were positive in 11.3% and thyroglobulin antibodies in 10.4%. Hypothyroidism of any kind was present in only 4.6% (0.3% overt, 4.3% subclinical). So most people with antibodies had a normal TSH.

Antibodies were more common in women and rose with age. Only TPO antibodies were significantly linked to hypothyroidism. Among pregnant women, a review in Journal of Thyroid Research reports that 10% to 20% are antibody positive with normal thyroid function.

How fast do antibodies progress to hypothyroidism?

The best long-term data come from the Whickham survey, which followed 2,779 British adults for 20 years. Among women, spontaneous hypothyroidism developed at 3.5 per 1,000 per year. The odds of developing hypothyroidism were 8 times higher with positive antibodies alone, 8 times higher with a raised TSH alone, and 38 times higher with both.

The AACE/ATA 2012 hypothyroidism guideline translates those odds into yearly rates: about 4% per year with both antibodies and a raised TSH, and 2% to 3% per year with either one alone.

Later cohorts agree. The Amsterdam AITD cohort followed 790 euthyroid women with a relative with autoimmune thyroid disease. Over 5 years, 7.5% developed overt thyroid disease (38 hypothyroid, 13 hyperthyroid), a mean of 1.5% per year. The Busselton study followed 1,184 Australians for 13 years. Among antibody-positive women, hypothyroidism (mostly subclinical) developed in 12.0% when baseline TSH was 2.5 mU/L or lower, 55.2% when TSH was 2.5 to 4.0, and 85.7% when TSH was above 4.0.

What raises the risk?

TSH level. This is the strongest predictor in every study. In a Swiss cohort of 82 women with subclinical hypothyroidism followed 9.2 years, overt hypothyroidism developed in 0% with a TSH of 4 to 6 mU/L, 42.8% with a TSH of 6 to 12, and 76.9% above 12. Positive antibodies raised progression from 23.2% to 58.5%. A Spanish study of 107 patients over 55 found 1.76 cases per 100 patient-years when TSH was 5.0 to 9.9, versus 19.67 when TSH was 10.0 to 14.9.

Antibody titer. Risk is level dependent. In the Amsterdam study, higher TPO antibody levels meant higher risk, and TSH risk began to climb above 2.0 mIU/L. The ATA 2017 pregnancy guideline notes that the highest titers carry the highest risk of postpartum thyroiditis.

Sex and age. NIDDK states Hashimoto's is 4 to 10 times more common in women. In Whickham, women developed hypothyroidism at 3.5 per 1,000 per year versus 0.6 in men. Both antibodies and hypothyroidism rise with age.

Family history. In the Amsterdam cohort, two relatives with Hashimoto's carried the greatest risk. A score combining TSH, antibody level, and family history predicted 5-year event rates from 2.7% to 76.9%.

Iodine. Both too little and too much iodine are linked to thyroid autoimmunity. When Denmark added iodine to salt, TPO antibody prevalence rose from 14.3% to 23.8% within 4 to 5 years. The AACE/ATA guideline lists excess iodine from kelp, plus lithium, amiodarone, and interferon alpha, as exposures that raise risk. Check supplements.md before starting any iodine or "thyroid support" product.

Should antibody-positive people with a normal TSH be treated?

Not outside pregnancy. NIDDK's guidance is direct: "If you don't have hypothyroidism, your doctor may choose to simply check your symptoms and thyroid hormone levels regularly." Levothyroxine replaces missing hormone. It does not stop the immune attack.

The AACE/ATA 2012 guideline treats antibodies as a prognostic tool, not a treatment trigger. Recommendation 1 says TPO antibodies should be measured when evaluating subclinical hypothyroidism, because a positive result predicts faster progression (4.3% versus 2.6% per year). Recommendation 16 says treatment may be considered when TSH is between the upper limit of normal and 10 mIU/L, particularly with symptoms, positive TPO antibodies, or cardiovascular risk. Both apply only once TSH is already high. We cover that decision in our post on subclinical hypothyroidism.

Selenium is not recommended for TPO antibody-positive women in pregnancy (ATA 2017, Recommendation 12). No trial shows any supplement prevents progression. See our Hashimoto's guide for what lifestyle changes can do.

What changes in pregnancy?

Pregnancy raises hormone demand, and an antibody-damaged gland may not keep up. The ATA 2017 guideline cites a study of antibody-positive euthyroid women whose mean TSH rose from 1.7 mU/L at week 12 to 3.5 mU/L at term. By delivery, 19% had a TSH above normal. The guideline's recommendations:

Euthyroid women who are TPOAb or TgAb positive should have TSH measured when pregnancy is confirmed and every 4 weeks through midpregnancy (Recommendation 11), plus at least once near 30 weeks (Recommendation 33).
Any pregnant woman with a TSH above 2.5 mU/L should be tested for TPO antibodies (Recommendation 28).
Levothyroxine is recommended for antibody-positive women whose TSH is above the pregnancy-specific range. For antibody-negative women, the threshold is a TSH above 10.0 mU/L (Recommendation 29).
For antibody-positive women with a normal TSH, evidence that levothyroxine reduces pregnancy loss is insufficient. It may be considered after a prior loss (Recommendation 14, weak). No recommendation exists for preventing preterm birth (Recommendation 15).

A 2025 meta-analysis of 8 randomized trials (1,645 antibody-positive euthyroid pregnant women) found levothyroxine cut miscarriage risk by 22% (RR 0.78, 95% CI 0.63 to 0.98). Preterm birth and live birth rates did not change significantly. ACOG Practice Bulletin 223 does not recommend universal thyroid screening in pregnancy. It advises testing women with risk factors such as prior thyroid or autoimmune disease.

After delivery, the immune system rebounds. The ATA guideline reports a 33% to 50% risk of postpartum thyroiditis in women who are antibody positive in the first trimester.

How often should you recheck?

No guideline fixes an interval for antibody-positive people with a normal TSH. NIDDK advises regular checks of symptoms and hormone levels. Most clinicians repeat TSH about once a year. Test sooner if:

You notice new fatigue, weight gain, cold intolerance, constipation, or hair loss.
You become pregnant. Testing then moves to every 4 weeks through midpregnancy.
You are in the 12 months after delivery.
Your last TSH was high-normal, above about 2.5 to 4.0 mU/L.
You start lithium, amiodarone, interferon, or high-dose iodine.

Two points save needless testing. First, do not repeat the antibody test. The AACE/ATA guideline notes these antibodies generally persist and rarely disappear. Second, one high TSH is not a diagnosis. In the Spanish cohort above, TSH returned to normal without treatment in 37.4% of patients. Repeat the test in 2 to 3 months before starting medication.

The bottom line

Thyroid antibodies are a risk marker, not a diagnosis. About 1 in 9 Americans has TPO antibodies; most have a normal TSH. With antibodies alone, hypothyroidism develops at roughly 2% to 3% per year. With antibodies plus a raised TSH, the rate is about 4% per year and climbs steeply as TSH rises. Outside pregnancy, treatment waits until TSH is high. In pregnancy, antibody-positive women need TSH checks every 4 weeks through midpregnancy. For everyone else, a yearly TSH and attention to symptoms is enough.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk to your doctor or endocrinologist about your own antibody and TSH results, especially if you are pregnant or planning a pregnancy.